Keywords: entremed, secures, 20m, financing, usa-based, clinical-stage, pharmaceutical

EntreMed secures $20M financing

Article | 24 September 2007

USA-based EntreMed, a clinical-stage pharmaceutical company developing drugs for cancer and inflammatory diseases, has completed a $20.0 million secured loan agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Thalidomide

Thalomid

Go to drug listing